The Food and Drug Administration granted approval for a second generic version of the abortion pill mifepristone , sparking outrage among anti-abortion conservatives, as it will likely increase the prevalence of medication abortions.

The FDA on Thursday approved the generic drug to be made by the telehealth abortion company Evita Solutions , according to a copy of the FDA approval letter obtained by the Washington Examiner .

Recommended Stories

CDC awards contract to RPI to study link between vaccines and autism

Trump directs $50 million to AI in childhood cancer research

FDA launches campaign pushing over 300,000 retailers to pull illegal vaping products

This marks the second approval of the abortion drug mifepristone, which was initially approved under the brand name

See Full Page